Phillip J Robinson

Title: The Innovations of Phillip J Robinson

Introduction

Phillip J Robinson is a notable inventor based in Fitzroy, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as protein kinase C inhibitors. With a total of three patents to his name, Robinson's work has implications for the treatment of various medical conditions, including hypertension and asthma.

Latest Patents

Robinson's latest patents include a process for preparing quinoline aldehyde and ketone derivatives. This invention relates to novel quinolyloxazole-2-ones, which are useful as protein kinase C inhibitors. The compounds developed through this process are effective in treating hypertension and asthma. Additionally, the invention includes a novel procedure for producing an intermediate ketone compound. This involves the reaction of a bromo-quinoline compound with butyl lithium, followed by further reactions with N-methyl-N-methoxyalkanamide.

Career Highlights

Phillip J Robinson has established a successful career at Merrell Dow Pharmaceuticals. His innovative work has contributed to advancements in pharmaceutical research and development. Robinson's expertise in chemistry and pharmacology has positioned him as a key figure in his field.

Collaborations

Throughout his career, Robinson has collaborated with notable colleagues, including Winton D Jones and George P Claxton. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Phillip J Robinson's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to impact the treatment of critical health conditions, showcasing the importance of innovation in medicine.